Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS
Home/The Filing Wire/HEPION PHARMACEUTICALS INC/ 10-Q

Quarterly Report · 10-Q

HEPION PHARMACEUTICALS INC

Quarterly Report

Filed May 14, 2026Accepted May 14, 2026, 4:35 PM EDTCIK 1583771Accession 0001493152-26-023136
View company →Permanent SEC source ↗
Share

Company context

Current securities

CTRVPOTC · PREFERRED · CurrentHEPAOTC · EQUITY · Current
Historical securities (4)
CTRVOTC · EQUITY · Historical · closed Feb 27, 2015CTRVWOTC · WARRANT · Historical · closed Jul 5, 2023HEPANASDAQ · EQUITY · Historical · closed May 12, 2025HEPAOTC · EQUITY · Historical · closed Oct 23, 2026

Recent company filings

  1. 4 filingOct 27, 2026
  2. SCHEDULE 13G/A - filed by RICKEL KENNETH regarding Hepion Pharmaceuticals, Inc.Oct 21, 2026
  3. S-8 filingOct 14, 2026
  4. Entry into a Material Definitive Agreement · Completion of Acquisition or Disposition of Assets · Unregistered Sales of Equity Securities · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsOct 9, 2026
  5. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearOct 2, 2026

Registered securities in this filing

HEPION PHARMACEUTICALS, INC. · 10-Q · Filed 2026-05-14

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock, par value $0.0001 per share

Symbol
HEPA
Exchange
Not supplied
Classification
COMMON
Filing context

Context: From2026-01-01to2026-03-31

Dimensions: Not supplied

Accession 000149315226023136 · 1 registered-security cover member

Read the exact SEC filing ↗

As-filed source

Primary evidence
As filedOpen full document ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.